A DECISIVE OVERVIEW ON THREE DIMENSIONAL PRINTING IN PHARMACEUTICALS
With the rapid pace of development in the pharmaceutical industries the researchers are equally contributing in developing the latest technology for their growth. The computer aided design and manufacturing that provides 3 dimensional (3D) printed dosage forms which the new step is being that to be taken into a consideration. With the Food and Drug Administration (FDA) approval to first 3D printed tablet in August 2015, Spritam®, since the 3D printing has become a novel method for the design of drug delivery system. It has the capability of dispensing the drug more accurately, precisely and layer by layer assembly which helps in forming complex composition and geometries. It enables the preparation of personalised dosage form and tailored release profiles. Therefore, it can be seen as a future of solid dosage forms produced on demand, with customised dose and in lower cost. It can also help in reducing side effects caused by excessive doses. This review highlights the 3D printing technology and its applications in growth of pharmaceutical sector. The novel technology is simple, rapid and design most complex things. Hence this technology can take drug delivery technology to another horizon
2. Ozkan T, Ienima M, Ali B, Manufacturing engineering challenges of pharmaceutical 3D printing for on demand drug delivery, Engineering technique open access journal, 2018; 1(5):001-003.
3. Deng, guang, yu, limin-zhu, Three dimensional printing of pharmaceutics. Journal of pharmaceutical science, 2009; 97(7): 3666-3690.
4. Prasad LK, Smith H, 3D printing technique for drug delivery: A review, Drug development and industrial pharmacy, 2015; 37(7):1019-1035.
5. Bhushnare OG, Gholve SV, 3D printing and pharmaceutical manufacturing opportunities and challenges, International journal of bioassay, 2016; 5(7):4723- 4738.
6. Bansal M, Sharma V, 3D printing for future of pharmaceutical dossage form, International journal of applied pharmaceutics, 2018; 10(3):1-7.
7. This is the first 3D printed drug to win FDA approval. http://www.computerworld.com.
8. Harshavardhan G, Hari Charan G, Reddy PV, Kumar KS, 3D Printing: The Dawn of a New Era in Manufacturing, International Journal on Recent and Innovation Trends in Computing and Communication, 2014; 2(8):2373- 2376.
9. Peter TM, Mawere C, Macdonald M, The Impact and Application of 3D Printing Technology, International Journal of Science and Research, 2014; 3(6):2148-2152.
10. Gokhare VG, Raut DN, Shinde DK, A Review paper on 3D-Printing Aspects and Various Processes Used in the 3D-Printing, International Journal of Engineering Research & Technology, 2017; 6(6):953- 958.
11. Bhandari S, Regina B, 3D Printing and its Applications, International Journal of Computer Science and Information Technology Research, 2014; 2(2):378-380.
12. Singh SB, Advanced manufacturing techniques(3d printing), International Journal of Mechanical and Production Engineering, 2016; 4(4):16-23.
13. Ramya A, Vanapalli SL, 3D printing technologies in various applications. International Journal of Mechanical Engineering and Technology, 2016; 7(3):396–409.
14. Shiwpursad J, Jianbin X, Comparison of Different Types of 3D Printing Technologies, International Journal of Scientific and Research Publications, 2018; 8(4):1-9.
15. Lepowsky E, Tasoglu S, 3D printing for drug manufacturing: A perspective on the future of pharmaceuticals, International journal of Bioprint, 2018; 4(1):119.
16. Reddy S, Madhava V, Reddy CS, 3D Printing Technologies and Processes – A Review, IOSR Journal of Engineering, 2017; 7(9):01-14.
17. Al-maliki J, Al-maliki A, The Processes and Technologies of 3D Printing. International Journal of Advances in Computer Science and Technology, 2015; 4(10):161-165.
18. Kazi MS, Jasvi UK, 3D printing: a new avenue in pharmaceuticals, World Journal of Pharmaceutical Research, 2016; 5(5):1686-1701.
19. Skowyra J, Pietrzak K, Alhnan MA, Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing, European Journal of Pharmaceutical Sciences, 2015; 68:11-7.
20. Goyanes A, Chang H, Sedough D, Hatton GB, Wang J, Buanz A, Gaisford SA, Basit AW, Fabrication of controlled release budesonide tablets via desktop (FDM) 3D printing, International Journal of Pharmaceutics, 2015; 496(2):414-420.
21. Goyanes A, Wang J, Buanz A, Pacheco RM, Telford R, Gaisford S, Basit AW, 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics, Mol. Pharmaceutics, 2015; 12(11):4077–4084.
22. Wang J, Goyanes A, Gaisford S, Basit AW, (Stereolithographic (SLA) 3D Printing of Oral Modified-Release Dosage Forms, International Journal of Pharmaceutics, 2016;503(1-2):207-212.
23. Jacob J, Coyle N, West TG, Monkhouse DC, Surprenant HL, Jain NB, Rapid disperse dosage form containing levetiracetam.
24. Maulvi FA, Shah MJ, Solanki BS, Patel AS, Soni TG, Application of 3D Printing Technology in the Development of Novel Drug Delivery Systems, Int J Drug Dev & Res, 2017; 9:44-49.
25. Katstra W, Palazzolo R, Rowe C, Giritlioglu B, Teung P, Oral dosage forms fabricated by Three Dimensional Printing™, Journal of controlled release, 2000;66(1-2):1-9.
26. Khaled SA, Burley JC, Alexander MR, Roberts CJ, Desktop 3D printing of controlled release pharmaceutical bilayer tablets, International journal of pharmaceutics, 2014; 461(1-2):105-111.
27. Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ, 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles, Journal of controlled release, 2015; 217:308-314.
28. Lee BK, Yun YH, Choi JS, Choi YC, Kim JD, Fabrication of drug loaded polymer microparticles with arbitrary geometries using a piezoelectric inkjet printing system, International journal of pharmaceutics, 2012;427(2):305-310.
29. Rattanakit P, Moulton SE, Santiago KS, Liawruangrath S, Wallace GG, Extrusion printed polymer structures: a facile and versatile approach to tailored drug delivery platforms, International journal of pharmaceutics, 2012; 422(1-2):254-263.
30. Rowe C, Katstra W, Palazzolo R, Giritlioglu B, Teung P, Multimechanism oral dosage forms fabricated by three dimensional printing™, Journal of controlled release, 2000; 66(1):11-17.
31. Wang CC, Tejwani MR, Roach WJ, Kay JL, Yoo J, Development of near zero-order release dosage forms using three-dimensional printing (3DP) technology, Drug development and industrial pharmacy, 2006; 32(3):367-376.
32. Melocchi A, Parietti F, Loreti G, Maroni A, Gazzaniga A, 3D printing by fused deposition modeling (FDM) of a swellable/erodible capsular device for oral pulsatile release of drugs, Journal of Drug Delivery Science and Technology, 2015; 30:360-367.
33. Yu DG, Branford-White C, Ma ZH, Zhu LM, Li XY, Novel drug delivery devices for providing linear release profiles fabricated by 3DP, International journal of pharmaceutics, 2009; 370(1-2):160-166.
34. Yu DG, Shen XX, Branford WC, Zhu LM, White K, Novel oral fast disintegrating drug delivery devices with predefined inner structure fabricated by Three Dimensional Printing, Journal of Pharmacy and Pharmacology, 2009;61(3):323-329.
35. Scoutaris N, Alexander MR, Gellert PR, Roberts CJ, Inkjet printing as a novel medicine formulation technique, Journal of controlled release, 2011;156:179-185.
36. Goyanes A, Det-Amornrat U, Wang J, Basit AW, Gaisford S, 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems, Journal of controlled release, 2016; 234:41-48.
37. Sadia M, Sośnicka A, Arafat B, Isreb A, Ahmed W, Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient tailored immediate release tablets, International journal of pharmaceutics, 2016; 513(1-2):659-668.
38. Genina N, Fors D, Vakili H, Ihalainen P, Pohjala L, et al., Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques, European Journal of Pharmaceutical Sciences, 2012; 47:615-623.
39. Yi HG, Choi YJ, Kang KS, Hong JM, Pati RG, A 3D-printed local drug delivery patch for pancreatic cancer growth suppression, Journal of controlled release, 2016; 238:231-141.
40. Genina N, Holländer J, Jukarainen H, Makila E, Salonen J, Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices, European Journal of Pharmaceutical Sciences, 2015; 90:53-63.
41. Yu DG, Branford-White C, Yang YC, Zhu LM, Welbeck EW, A novel fast disintegrating tablet fabricated by three-dimensional printing, Drug development and industrial pharmacy, 2009; 35(12):1530-1536.
42. Yu DG, Yang XL, Huang WD, Liu J, Wang YG, Tablets with material gradients fabricated by three-dimensional printing, Journal of pharmaceutical sciences, 2007; 96(9):2446-2456.
43. Goyanes A, Wang J, Buanz A, Martínez-Pacheco R, Telford R, 3D printing of medicines: engineering novel oral devices with unique design and drug release characteristics, Molecular pharmaceutics, 2015; 12:4077-4084.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).